Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers With Topical Pharmaceutical Agents

Allergic rhinitis (AR) is a chronic upper respiratory disease estimated to affect between 10 and 40% of the worldwide population. The mechanisms underlying AR are highly complex and involve multiple immune cells, mediators, and cytokines. As such, the development of a single drug to treat allergic i...

Descripción completa

Detalles Bibliográficos
Autores principales: Watts, Annabelle M., Cripps, Allan W., West, Nicholas P., Cox, Amanda J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455085/
https://www.ncbi.nlm.nih.gov/pubmed/31001114
http://dx.doi.org/10.3389/fphar.2019.00294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455085/
https://www.ncbi.nlm.nih.gov/pubmed/31001114
http://dx.doi.org/10.3389/fphar.2019.00294

Ejemplares similares